Burden of Streptococcus pneumoniae sepsis in children after introduction of pneumococcal conjugate vaccines - a prospective population-based cohort study.

Asner, Sandra A; Agyeman, Philipp; Gradoux, Eugénie; Posfay-Barbe, Klara M; Heininger, Ulrich; Giannoni, Eric; Crisinel, Pierre A; Stocker, Martin; Bernhard-Stirnemann, Sara; Niederer-Loher, Anita; Kahlert, Christian R; Hasters, Paul; Relly, Christa; Baer, Walter; Aebi, Christoph; Schlapbach, Luregn Jan; Berger, Christoph (2019). Burden of Streptococcus pneumoniae sepsis in children after introduction of pneumococcal conjugate vaccines - a prospective population-based cohort study. Clinical infectious diseases, 69(9), pp. 1574-1580. The University of Chicago Press 10.1093/cid/ciy1139

[img] Text
ciy1139.pdf - Accepted Version
Restricted to registered users only until 3 January 2020.
Available under License Publisher holds Copyright.

Download (1MB) | Request a copy

Background Population-based studies assessing the impact of pneumococcal conjugate vaccines (PCV) on burden of pneumococcal sepsis in children are lacking. We aimed to assess this burden following introduction of PCV-13 in a nationwide cohort study. Methods The Swiss Pediatric Sepsis Study (09/2011-12/2015) prospectively recruited children <17 years of age with blood culture-proven sepsis due to Streptococcus pneumoniae, meeting criteria for systemic inflammatory response syndrome. Infection with vaccine serotype in children up to date with PCV immunization was defined as vaccine failure. Main outcomes were admission to pediatric intensive care unit (PICU) and length of hospital stay (LOS). Results Children with pneumococcal sepsis (n=117) accounted for a crude incidence of 2.0 per 100,000 children (95% CI 1.7-2.4) and 25% of community-acquired sepsis episodes. Case fatality rate was 8%. 42 (36%) patients required PICU admission. Children with meningitis (29; 25%) were more often infected by serotypes not included in PCV (69% vs 31%; p<0.001). 16 (26%) of 62 children up to date with PCV immunization presented with vaccine failure, including 11 infected with serotype 3. In multivariable analyses, children with meningitis (OR 6.8; 95% C.I 2.4-19.3; p<0.001), or infected with serotype 3 (OR 2.8; 95% C.I 1.1- 7.3; p=0.04) were more often admitted to PICU. Children infected with serotype 3 had longer LOS ( coefficient 0.2, 95% CI 0.1-1.1; p=0.01). Conclusions The incidence of pneumococcal sepsis in children shortly after introduction of PCV-13 remained substantial. Meningitis mostly due to non-vaccine serotypes and disease caused by serotype 3 represented significant predictors of severity.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Paediatric Medicine
04 Faculty of Medicine > Service Sector > Institute for Infectious Diseases > Research
04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Paediatric Medicine > Paediatric Infectiology
04 Faculty of Medicine > Service Sector > Institute for Infectious Diseases

UniBE Contributor:

Agyeman, Philipp; Aebi, Christoph and Schlapbach, Luregn Jan

Subjects:

600 Technology > 610 Medicine & health
500 Science > 570 Life sciences; biology

ISSN:

1058-4838

Publisher:

The University of Chicago Press

Funders:

[4] Swiss National Science Foundation
[UNSPECIFIED] Swiss Society of Intensive Care
[24] Gottfried und Julia Bangerter- Rhyner Stiftung
[72] Vinetum Foundation
[UNSPECIFIED] the Foundation for the Health of Children and Adolescents

Language:

English

Submitter:

Philipp Agyeman

Date Deposited:

05 Feb 2019 14:26

Last Modified:

04 Nov 2019 08:49

Publisher DOI:

10.1093/cid/ciy1139

PubMed ID:

30601988

BORIS DOI:

10.7892/boris.123822

URI:

https://boris.unibe.ch/id/eprint/123822

Actions (login required)

Edit item Edit item
Provide Feedback